Biochemical target and mechanism of action
The site of action of indirect anticoagulants is the liver. Normally, the active form of vitamin K (hydroquinone) acts as a coenzyme in the $\gamma$-carboxylation reaction of glutamic acid residues (converting it to gamma-carboxyglutamic acid). This process is critically important for the formation of functionally competent clotting factors (II, VII, IX, and X) capable of binding calcium.
During carboxylation, hydroquinone is oxidized into an inactive epoxide. For reuse, it must be reduced back with the help of enzymes: vitamin K reductase, epoxide reductase, and DT-diaphorase.
The drugs block these reductase enzymes. As a result, active vitamin K stores are depleted, and the maturation of clotting factors (specifically prothrombin) ceases.
Time characteristics and cumulation
A pharmacodynamic feature of the group is a pronounced latent period. The effect develops slowly, and the maximum effect (e.g., for acenocoumarol) occurs after 48 hours or more.
The delay is due to the fact that the drugs do not affect proteins already circulating. The anticoagulant effect appears only as the existing prothrombin complex factors undergo natural degradation (destruction).
After drug discontinuation, the effect persists for a prolonged period—about 2–5 days. In addition, these medicinal products are characterized by material cumulation (accumulation of the substance itself in the body).
Pharmacokinetics and metabolism of warfarin
The drugs are administered orally (per os), have high bioavailability (about 90%) and a very high degree of plasma protein binding (90–95%). Metabolism occurs in the liver involving the cytochrome P-450 system. The half-life ranges from 30 to 60 hours.
Warfarin is a racemic mixture:
- S-isomer is 4–5 times more active than the R-isomer and is oxidized exclusively by the CYP 2C9 isoenzyme.
- R-isomer is metabolized by other isoenzymes (CYP 2C19, 3A4).
Genetic polymorphism of the CYP 2C9 isoenzyme is the main reason for interindividual differences in sensitivity to warfarin and the severity of the anticoagulant effect in different patients.
Clinical use and safety
Indications: long-term prevention and treatment of deep vein thrombosis, pulmonary embolism, myocardial infarction. They are also used to prevent blood clot formation in the postoperative period, in atrial fibrillation, and after heart valve replacement.
Side effects: the most frequent complication is bleeding. The risk is significantly increased with the concurrent use of antiplatelet agents (e.g., aspirin). Allergic reactions, diarrhea, liver dysfunction, and specific skin necrosis are possible. Phenindione additionally carries the risk of bone marrow suppression.
Interactions: due to high protein affinity, anticoagulants can be displaced by other drugs (e.g., sulfonamides). This leads to an increase in the free fraction of the anticoagulant and a sharp risk of bleeding.
Pregnancy: strictly contraindicated. They easily cross the placental barrier and exert a teratogenic effect (suppress the formation of the vitamin-K-dependent bone protein osteocalcin, disrupting skeletal development). At the same time, warfarin poorly penetrates breast milk and is permitted during lactation.
Emergency care for bleeding
To stop bleeding caused by an overdose of indirect anticoagulants, the following are used:
- Vitamin $K_1$ preparations act as a pathogenetic antidote.
- Prothrombin complex concentrate provides rapid replenishment of clotting factor deficiency (contains vitamin-K-dependent factors II, VII, IX, and X).
Briefly: answers to topical questions
What chemical classes are indirect anticoagulants divided into, and which drugs belong to them?
- Coumarin derivatives (coumarin derivatives) — acenocoumarol (sincumar), warfarin.
- Indandione derivatives (indandione derivatives) — phenindione (phenilin).
Indirect anticoagulants are divided into two main chemical classes. Coumarin derivatives include acenocoumarol (sincumar) and warfarin. Indandione derivatives include phenindione (phenilin). These medicinal products inhibit the synthesis of clotting factors in the liver, acting as vitamin K antagonists.
Which groups of medicinal products are capable of displacing indirect anticoagulants from plasma protein binding?
- Sulfonamides (Sulfanilamida) — can displace indirect anticoagulants, such as warfarin, from plasma protein/albumin binding.
Indirect anticoagulants have a high degree of plasma protein binding. When warfarin is displaced by sulfonamides, the concentration of the free active anticoagulant fraction increases, leading to a sharp decrease in blood clotting and an increased risk of massive bleeding.
What absolute and relative contraindications exist for prescribing indirect anticoagulants, besides pregnancy?
- Severe liver diseases — a contraindication to prescribing vitamin K antagonists.
Besides pregnancy, sources indicate that prescribing vitamin K antagonists to patients with severe liver disease is contraindicated. The reason is the difficulty of use due to baseline INR elevation, coagulopathy, and difficulties in subsequent INR assessment/monitoring.
Which blood parameter and with what target values must be monitored during warfarin treatment?
- International Normalized Ratio (INR) — an indicator for monitoring therapy with warfarin/vitamin K antagonists.
- Target INR values for VKA monotherapy — 2.0–3.0.
- For a mechanical heart valve prosthesis and atrial fibrillation the target INR is 3, the acceptable range is 2.5–3.5.
Laboratory monitoring is required during warfarin treatment. For patients receiving vitamin K antagonists, the monitoring method is determining the INR. Time in the therapeutic range should be more than 70% of observations.
What is the pathogenetic mechanism of development of specific skin necrosis when taking indirect anticoagulants?
- Skin necrosis — a specific non-hemorrhagic complication of therapy with indirect anticoagulants.
- Protein C deficiency — a high-risk factor for the development of warfarin-induced skin necrosis at the start of vitamin K antagonist therapy.
- Protein S deficiency — also associated with an increased risk of warfarin-induced skin necrosis.
In the cited sources, the pathogenetic mechanism of warfarin-induced skin necrosis is not detailed. It is indicated that patients with protein C deficiency and decreased free protein S have an increased risk of this complication.
Class and exam questions
Why is the effect of indirect anticoagulants delayed?
The drugs do not destroy pre-existing clotting factors in the blood. The effect occurs only after 48 hours or more, when older prothrombin complex proteins break down naturally.
Which blood parameter must be monitored during treatment?
It is necessary to measure prothrombin time regularly. Its value directly depends on the concentration of prothrombin, as well as factors IX and X, whose synthesis is suppressed.
Why is it hazardous to prescribe warfarin together with sulfonamides?
Sulfonamides displace anticoagulants from plasma protein binding. Because of this, the concentration of the free (active) fraction of the drug in the blood sharply increases, which can provoke severe bleeding.
Can indirect anticoagulants be prescribed during pregnancy?
No, they are strictly contraindicated. The drugs cross the placenta and suppress the formation of osteocalcin, causing severe fetal skeletal development disorders.
What else to study on this topic
- Chemical structure of coumarin derivatives (warfarin, acenocoumarol)
- Stereoisomerism of warfarin and the difference in activity of R- and S-isomers
- Mechanism of development of specific skin necrosis
- Hematotoxicity of phenindione and risks of blood suppression
- Properties of phytomenadione as a water-soluble vitamin K analogue
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on «Indirect Anticoagulants» and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Drugs affecting hemostasis and thrombosis"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.